Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siliang Gong

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Multivariate Analysis|January 8, 2019
Efficient test-based variable selection for high-dimensional linear modelsSiliang Gong, Kai Zhang, Yufeng Liu
Cancer Research|January 30, 2021
Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast CancerChristoforos Thomas, Ilias V Karagounis, Ratnesh K Srivastava, et al.
Cancer Research Communications|August 20, 2025
Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal CancerRona Yaeger, Jean-François Martini, Lincoln Pasquina, et al.
Plos One|August 1, 2025
Analytical validation and sequencing coverage studies suggest that performance of a liquid biopsy assay is tumor agnostic (DNA-is-DNA)Wei Meng, Russell Petry, Norberto Pantoja Galicia, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Multivariate Analysis|January 8, 2019
Efficient test-based variable selection for high-dimensional linear modelsSiliang Gong, Kai Zhang, Yufeng Liu
Cancer Research|January 30, 2021
Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast CancerChristoforos Thomas, Ilias V Karagounis, Ratnesh K Srivastava, et al.
Cancer Research Communications|August 20, 2025
Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal CancerRona Yaeger, Jean-François Martini, Lincoln Pasquina, et al.
Plos One|August 1, 2025
Analytical validation and sequencing coverage studies suggest that performance of a liquid biopsy assay is tumor agnostic (DNA-is-DNA)Wei Meng, Russell Petry, Norberto Pantoja Galicia, et al.
Pageof 1